MedTrace Logo

Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion

NCT02868437 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-08-16

No results posted yet for this study

Summary

This prospective, randomized, controlled study evaluates the efficacy of self-crosslinked hyaluronic acid gel to prevent the development of de-novo intrauterine adhesions following curettage for retained product after second trimester abortion. One group of participants will underwent curettage plus intrauterine application of self-crosslinked hyaluronic acid gel while the other group will underwent curettage alone (control group).

Conditions

  • Placenta Retained
  • Uterine Diseases

Interventions

DEVICE

intrauterine self-cross-linked hyaluronic acid gel

intrauterine self-cross-linked hyaluronic acid gel will apply after curettage for retained product after second trimester abortion

Sponsors & Collaborators

  • Bilar Medikal, Turkey

    collaborator UNKNOWN

  • Istanbul University

    lead OTHER

Principal Investigators

  • Ozlem Dural, M.D. · Istanbul University School Of Medicine, Department of Obstetrics and Gynecology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02868437 on ClinicalTrials.gov